Publication Cover
Synthetic Communications
An International Journal for Rapid Communication of Synthetic Organic Chemistry
Volume 50, 2020 - Issue 20
360
Views
5
CrossRef citations to date
0
Altmetric
Articles

Novel 2-(2-hydrazinyl)thiazole derivatives as chemotherapeutic agents

ORCID Icon, &
Pages 3072-3079 | Received 07 May 2020, Published online: 15 Jul 2020
 

Abstract

A series of 2-(2-hydrazinyl)thiazole derivatives containing diarylsulfide moiety were synthesized and investigated for their antibacterial and antifungal activities. Compound 3j, namely 2-[2-[4-((4-fluorophenyl)thio)benzylidene]hydrazinyl]-4-(4-methylphenyl)thiazole was determined as the most potent antifungal agent. It was further tested to detect the apoptosis induction ratio on Candida spp. which is a new approach to identify the mechanism of action responsible for antifungal potency. Also, the inhibitory activity of all the target compounds against healthy cell line, NIH3T3, and tumor cell lines A549, Caco2, MCF-7, HL60, and K562 was determined by MTT assay. The activity results were found moderate and the first seven derivatives containing chloro substituent (3a–3g) exhibited more antiproliferative activity than those containing fluoro substituent.

Graphical Abstract

Correction Statement

This article has been republished with minor changes. These changes do not impact the academic content of the article.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.